Price Alert

BioMarin Pharmaceutical I... (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

58.02

-0.28 (-0.48%)

At close: Aug 14, 2025, 3:59 PM

58.07

0.09%

Pre-market: Aug 15, 2025, 09:08 AM EDT

BioMarin Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	3.05B	2.94B	2.84B	2.75B	2.59B	2.48B	2.42B	2.31B	2.23B	2.17B	2.1B	2.01B	1.91B	1.88B	1.85B	1.85B	1.92B	1.84B
Cost of Revenue	626.24M	620.91M	608.83M	608.17M	560.14M	559.06M	561.84M	553.65M	529.51M	508.95M	483.67M	476.13M	463.38M	467.31M	470.51M	476.9M	562.16M	533.06M
Gross Profit	2.43B	2.32B	2.23B	2.14B	2.03B	1.92B	1.86B	1.76B	1.7B	1.66B	1.61B	1.53B	1.45B	1.41B	1.38B	1.37B	1.35B	1.31B
Operating Income	776.08M	602.65M	460.62M	313.43M	222.37M	175.68M	154.29M	126.14M	106.08M	88.46M	57.99M	6.04M	-49.95M	-77.43M	-82.34M	-61.3M	-64.02M	-116.64M
Interest Income	73.57M	74.53M	74.88M	75.25M	72.93M	65.76M	58.34M	49.01M	38.26M	28.16M	18.03M	11.07M	7.9M	9.86M	10.48M	11.81M	13.98M	13.8M
Pretax Income	840.04M	674.3M	541.76M	391.45M	298.68M	237.35M	188.56M	151.68M	108.11M	72.15M	149.58M	100.56M	56.3M	35.61M	-75.35M	-48.96M	-64.02M	-120.45M
Net Income	657.24M	523.88M	426.86M	322.29M	256.59M	205.46M	167.65M	147.02M	99.99M	71.61M	141.56M	83.91M	54.07M	39.35M	-64.08M	15.92M	837.21M	795.09M
Selling & General & Admin	972.68M	1B	1.02B	1.01B	933.16M	886.91M	882.79M	853.5M	897.72M	877.77M	854.01M	825.83M	792.35M	779.68M	759.38M	737.32M	733.44M	724.69M
Research & Development	678.45M	700.93M	747.18M	779.92M	786.34M	779.91M	746.77M	713.27M	679.79M	660.62M	649.61M	637.95M	637.99M	640.9M	628.79M	624.37M	613.55M	634.58M
Other Expenses	24.36M	14.99M	10.14M	-14.75M	-15.72M	-8.11M	-8.11M	23.39M	36.17M	49.58M	67.19M	52.34M	44.44M	29.95M	13.2M	17.05M	9.36M	9.87M
Operating Expenses	1.66B	1.72B	1.78B	1.83B	1.81B	1.74B	1.7B	1.64B	1.61B	1.59B	1.57B	1.53B	1.5B	1.49B	1.46B	1.43B	1.42B	1.43B
Interest Expense	3K	6.26M	12.67M	16.19M	17M	17.18M	17.34M	14.86M	15.76M	15.87M	15.97M	16.19M	15.38M	15.34M	15.34M	16.24M	21.97M	26.2M
Selling & Marketing Expenses	143.4M	266.2M	266.2M	364.9M	377.9M	370.7M	488.4M	479.8M	469.2M	463M	450.2M	438.7M	424.4M	415.9M	405.2M	292.1M	195.1M	191.2M
Cost & Expenses	2.29B	2.34B	2.39B	2.44B	2.37B	2.3B	2.27B	2.2B	2.14B	2.1B	2.05B	2.01B	1.96B	1.96B	1.93B	1.91B	1.98B	1.96B
Income Tax Expense	182.8M	150.42M	114.9M	69.16M	42.09M	31.9M	20.92M	4.66M	8.11M	531K	8.02M	16.65M	2.23M	-3.74M	-11.27M	-64.88M	-901.23M	-915.54M
Shares Outstanding (Basic)	191.44M	190.97M	190.69M	190.43M	190.11M	188.87M	188.48M	188.22M	187.95M	186.67M	186.03M	185.6M	185.25M	190.53M	181.6M	182.47M	182.84M	181.77M
Shares Outstanding (Diluted)	196.64M	196.47M	196.58M	197.15M	200.5M	199.26M	191.84M	191.17M	195M	194.36M	186.03M	185.6M	187.45M	194.89M	183.55M	183.21M	185.43M	184.37M
EPS (Basic)	3.46	2.76	2.26	1.71	1.35	1.09	0.89	0.78	0.53	0.38	0.74	0.42	0.26	0.18	-0.35	0.09	4.62	4.39
EPS (Diluted)	3.38	2.69	2.18	1.65	1.31	1.05	0.87	0.76	0.51	0.37	0.73	0.41	0.25	0.17	-0.36	0.08	4.29	4.06
EBITDA	882.65M	738.3M	650.86M	507.32M	422.04M	359.85M	310.28M	268.42M	224.87M	188.87M	267.32M	219.56M	176.53M	157.74M	47.43M	67.97M	49.23M	-15.27M
EBIT	544.85M	680.56M	554.43M	407.04M	315.08M	253.94M	205.3M	165.95M	123.28M	87.42M	164.95M	116.16M	71.09M	50.35M	-60.61M	-32.72M	-42.05M	-94.77M
Depreciation & Amortization	42.61M	57.74M	96.43M	99.68M	106.36M	105.31M	104.39M	101.88M	101M	100.85M	101.77M	103.4M	105.44M	107.38M	108.04M	100.69M	91.28M	78.98M